Blood pressure in Spain: Distribution, awareness, control, and benefits of a reduction in average pressure

Hypertension

Volumn 32, Issue 6, 1998, Pages 998-1002

  Banegas, José R ^a   Rodríguez Artalejo, Fernando ^b   De La Cruz Troca, Juan José ^a   Guallar Castillón, Pilar ^a   Del Rey Calero, Juan ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Awareness; Blood pressure; Cross sectional studies; Hypertension, arterial; Prevalence

Indexed keywords

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; SPAIN;

EID: 0344097511     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.6.998     Document Type: Article

References (37)

1. Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101-106.
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V). Arch Intern Med. 1993;153:154-183.
3. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med. 1997;157:2413-2446.
4. World Health Organization. Hypertension Control. Report of a WHO Expert Committee. WHO Technical Report Series 862. Geneva, Switzerland: World Health Organization; 1996.
5. Rose GA. The Strategy of Preventive Medicine. Oxford, UK: Oxford University Press; 1992.
6. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 1993; 153:598-615.
7. Ministerio de Sanidad y Consumo y Sociedad-Liga Española para la lucha contra la hipertensión arterial. Control de la hipertensión arterial en España, 1996. Rev Esp Salud Pub. 1996;70:139-210.
8. Banegas JR, Villar F, Pérez C, Jiménez R, Gil E, Muñiz J, Juane R. Estudio epidemiológico de los factores de riesgo cardiovascular en la población española de 35 a 64 años. Rev San Hig Pub. 1993;67:419-455.
9. World Health Organization. Arterial Hypertension. Report of a WHO Expert Committee. WHO Technical Report Series 628. Geneva, Swit́ zerland: World Health Organization; 1978.
10. Kish L. Survey Sampling. New York, NY: John Wiley & Sons; 1965.
11. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan KM, Fagan RF, Arner TG. Epi Info Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, Ga: Centers for Disease Control and Pré vention; 1994.
12. World Health Organization. World Health Statistics Annual. Geneva, Switzerland: World Health Organization; 1994.
13. Norusis MJ. SPSS/PC+. Advanced Statistics, Version 4.0. Chicago, Ill: SPSS Inc; 1990.
14. Stamler J, Rose GA, Stamler R, Elliott P, Dyer A, Marmot M. INTERSALT study findings: public health and medical care implications. Hypertension. 1989;14:570-577.
15. National High Blood Pressure Education Program Working Group. Report on Primary Prevention of Hypertension. Arch Intern Med. 1993; 153:186-208.
16. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275:1590-1597.
17. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetky LP, Sacks F, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin P, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
18. Ruilope LM, Aranda P, Coca A, Córdoba R, Gil V, Rodicio JL, Luque M, Redón J, Roca-Cusachs A, Banegas JR, Brotons C. Situación actual de la detección, tratamiento y control de la HTA en España. Madrid, Spain: Liga Española para la Lucha contra la Hipertensión Arterial, 1995.
19. Armario P, Hernández R, Gasulla JM, Alonso A, Tresserras R, Pardell H. Prevalencia de hipertensión arterial en l'Hospitalet de Llobregat. Med Clin (Barc). 1990;94:570-575.
20. Paluzie G, Sans S, Puig T, Pérez I, Balañà L, Balaguer-Vintró I. Trends in awareness, treatment and control of hypertension in Monica-Catalonia. Can J Cardiol. 1997;13(suppl B):340B. Abstract.
21. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
22. Whelton PK, He J, Appel LJ. Treatment and prevention of hypertension. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, eds. Prevention of Myocardial Infarction. New York, NY: Oxford University Press; 1996.
23. Yen C-J, Pan W-P. Incidence of hypertension, isolated systolic hypertension, and isolated diastolic hypertension, and their risk factors in Chinese in Taiwan. Can J Cardiol. 1997;13(suppl B):339B. Abstract.
24. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risk of stroke and of coronary heart disease. Br Med Bull. 1994;50:272-298.
25. International Task Force for Prevention of Coronary Heart Disease. Prevention of Coronary Heart Disease: scientific background and new clinical guidelines - recommendations of the European Atherosclerosis Society. Nutr Metab Cardiovasc Dis. 1992;2:113-156.
26. Keil U, Kuulasmaa K, for the WHO MONICA Project. WHO MONICA project: risk factors. Int J Epidemiol. 1989;18(suppl 1):S46-S55.
27. ERICA Research Group. The CHD Risk Map of Europe: the 1st report of the WHO-ERICA Project. Eur Heart J. 1988;9(suppl I):1-36.
28. Guallar P, Rodríguez-Artalejo F, Banegas JR, Guallar E, Rey J. Cerebrovascular disease mortality in Spain, 1955-1992: an age-period-cohort analysis. Neuroepidemiology. 1997;16:116-123.
29. Stegmayr B, Asplund K, Kuulasmaa K, Rajakangas A, Thorvaldsen P, Tuomilehto J. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA project: an ecological study of 18 populations. Stroke. 1997;28:1367-1374.
30. Banegas JR, Graciani A, Rodriguez-Artalejo F. Hypertension control as an indicator of the geographical variation of stroke. Stroke. 1998;29: 867-868.
31. Nieto FJ, Alonso J, Chambless LE, Zhong M, Ceraso M, Romm FJ, Cooper L, Folsom AR, Szklo M. Population awareness and control of hypertension and hypercholesterolemia: the Atherosclerosis Risk in Communities study. Arch Intern Med. 1995;155:677-684.
32. Klein LE. Compliance and blood pressure control. Hypertension. 1988; 11(suppl II):II-61-II-64.
33. Puras A. El tratamiento no funciona o el paciente no cumple la prescripción? Med Clin (Barc). 1997;109:709-711.
34. Tormo MJ, Navarro C, Chirlaque MD, Pérez-Flores D. Prevalence and control of arterial hypertension in the south-east of Spain: a radical but still insufficient improvement. Eur J Epidemiol. 1997;13:301-308.
35. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetiére P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997;30:1410-1415.
36. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J. 1993;125:1148-1154.
37. Rodríguez-Artalejo F, Guallar P, Banegas JR, Rey J. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J. 1997;18:1771-1779.